JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1176
CALL
Caterpillar
CAT
$389B
| $41.8M | 0.01% |
182,600
+21,100
| +13% | +$5.1M |
2020 Q3
10 quarters
|
|
1177
OSI Systems
OSIS
$3.14B
| $41.7M | 0.01% |
407,770
+53,343
| +15% | +$4.94M |
2014 Q2
35 quarters
|
|
1178
Bio-Techne
TECH
$11.4B
| $41.6M | 0.01% |
560,985
+40,902
| +8% | +$3.15M |
2015 Q3
30 quarters
|
|
1179
Vanguard Morningstar Small-Cap Value ETF
VBR
$35.5B
| $41.5M | 0.01% |
261,368
+40,900
| +19% | +$6.77M |
2015 Q2
31 quarters
|
|
1180
Golub Capital BDC
GBDC
$3.26B
| $41.4M | 0.01% |
3,050,400
+92,007
| +3% | +$1.24M |
2015 Q4
29 quarters
|
|
1181
Hasbro
HAS
$12.6B
| $41.2M | 0.01% |
768,015
+75,415
| +11% | +$4.31M |
2013 Q2
39 quarters
|
|
1182
CALL
AbbVie
ABBV
$464B
| $41.1M | 0.01% |
258,000
-33,400
| -11% | -$5.11M |
2018 Q2
19 quarters
|
|
1183
Coherus Oncology
CHRS
$179M
| $40.9M | 0.01% |
5,982,535
-522,328
| -8% | -$4.05M |
2014 Q4
33 quarters
|
|
1184
iShares Select U.S. REIT ETF
ICF
$2.03B
| $40.7M | 0.01% |
732,125
-8,807
| -1% | -$501K |
2013 Q2
39 quarters
|
|
1185
PUT
Merck
MRK
$356B
| $40.6M | ﹤0.01% |
381,200
-551,200
| -59% | -$59.5M |
2021 Q2
7 quarters
|
|
1186
Blackstone Secured Lending
BXSL
$5.5B
| $40.4M | ﹤0.01% |
1,620,403
+84,139
| +5% | +$2.06M |
2021 Q4
5 quarters
|
|
|
CHX
1187
DELISTED
ChampionX
CHX
| $40.4M | ﹤0.01% |
1,488,527
+76,693
| +5% | +$2.29M |
2018 Q2
19 quarters
|
|
1188
Vanguard Russell 2000 ETF
VTWO
$16.5B
| $40.1M | ﹤0.01% |
555,702
-17,636
| -3% | -$1.31M |
2013 Q2
39 quarters
|
|
1189
Idacorp
IDA
$7.68B
| $40M | ﹤0.01% |
369,618
+52,490
| +17% | +$5.51M |
2013 Q2
39 quarters
|
|
1190
Elbit Systems
ESLT
$32.6B
| $39.8M | ﹤0.01% |
233,957
+149,903
| +178% | +$25.5M |
2013 Q2
39 quarters
|
|
1191
Pinnacle Financial Partners Inc
PNFP
$14.5B
| $39.8M | ﹤0.01% |
720,915
-140,120
| -16% | -$9.83M |
2013 Q2
39 quarters
|
|
1192
Watts Water Technologies
WTS
$12.1B
| $39.7M | ﹤0.01% |
236,061
+16,433
| +7% | +$2.71M |
2013 Q2
39 quarters
|
|
1193
iShares Emerging Markets Equity Factor ETF
EMGF
$1.96B
| $39.6M | ﹤0.01% |
954,794
+907,403
| +1,915% | +$38.1M |
2022 Q4
1 quarter
|
|
1194
First Financial Bankshares
FFIN
$4.61B
| $39.4M | ﹤0.01% |
1,235,956
-1,176,649
| -49% | -$40.9M |
2013 Q2
39 quarters
|
|
1195
AGNC Investment
AGNC
$10.4B
| $39.3M | ﹤0.01% |
3,899,372
+461,079
| +13% | +$5.01M |
2013 Q2
39 quarters
|
|
1196
Fidelity National Information Services
FIS
$16.7B
| $39.2M | ﹤0.01% |
722,326
-596,356
| -45% | -$38.8M |
2013 Q2
39 quarters
|
|
1197
CALL
argenx
ARGX
$57.5B
| $39.2M | ﹤0.01% |
105,300
+101,300
| +2,533% | +$37.5M |
2022 Q4
1 quarter
|
|
|
AXON
1198
Axon Enterprise
AXON
$33.6B
| $39M | ﹤0.01% |
173,573
+54,197
| +45% | +$10.8M |
2013 Q2
39 quarters
|
|
1199
PUT
ARK Innovation ETF
ARKK
$7.99B
| $39M | ﹤0.01% |
966,900
+267,000
| +38% | +$10.2M |
2021 Q1
8 quarters
|
|
|
DSEY
1200
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $38.9M | ﹤0.01% |
4,808,637
-1,389,509
| -22% | -$8.82M |
2021 Q1
8 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.